Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: Importance of BMP2

Cytokine

Volumn 11, Issue 12, 1999, Pages 1031-1037

  Arnold, S F ^a   Tims, E ^a   McGrath, B E ^a  

^a BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

Bone morphogenetic protein; Breast; Cancer cells; Molecular beacon; Radiation

Indexed keywords

ANTIBODY; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; CELL RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IRRADIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033372736     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0508     Document Type: Article

References (14)

1. Coleman, RE, Ruben, RD, The clinical course of bone metastases from breast cancer, Br J Cancer, 55, 61, 66.
2. Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat. 32:1994;73-84.
3. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science. 242:1988;1528-1534.
4. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop. 346:1998;26-37.
5. Zhou S, Buckhaults P, Zawel L, Bunz F, Riggins G, Dai JI, Kern SE, Kinzler KW, Vogelstein B. Targeted deletion of SMAD4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci U S A. 95:1998;2412-2416.
6. Thomsen GH. Antagonism within and around the organizer BMP inhibitors in vertebrate body patterning. Trends Genet. 13:1997;209-211.
7. Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate. 24:1994;204-211.
8. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T, Terada M. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res. 57:1997;5022-5027.
9. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE, Dale TC. Regulation of MSX-1, MSX-2, BMP-2 and BMP-4 during fetal and postnatal mammary gland development. Dev. 122:1996;2729-2737.
10. Tyagi S, Kramer FR. Molecular beacons probes that fluoresce upon hybridization. Nature Biotechnol. 14:1996;303-308.
11. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 48:1987;417-428.
12. Arrick BA, Korc M, Derynck R. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Cancer Res. 50:1990;299-303.
13. Chen C, Wang X-F, Sun L. Expression of transforming growth factor beta (TGFbeta) Type III receptor restores autocrine TGFbetal activity in human breast cancer MCF-7 cells. J Biol Chem. 272:1997;12 862-12 867.
14. Soda H, Raymond E, Sharma S, Lawrence R, Cerna C, Gomez L, Timony GA, Von Hoff DD, Izbicka E. Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anti-Cancer Drugs. 9:1998;327-331.